z-logo
open-access-imgOpen Access
HIV prevention and treatment in Southern Europe in the aftermath of bailout programmes
Author(s) -
Gonçalo Figueiredo Augusto,
Ioannis Hodges-Mameletzis,
Marina Karanikolos,
Alexandre Abrantes,
Maria do Rosário Oliveira Martins
Publication year - 2020
Publication title -
european journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 91
eISSN - 1464-360X
pISSN - 1101-1262
DOI - 10.1093/eurpub/ckaa062
Subject(s) - bailout , human immunodeficiency virus (hiv) , medicine , political science , business , virology , economics , keynesian economics , financial crisis
Background The global financial crisis impacted public health in Europe, and had a particularly critical detriment to health systems in Southern Europe. We aim to describe HIV response and progress towards the current global HIV targets in specific Southern European countries, which received financial adjustment programmes. Methods We examined and compared a set of HIV indicators in Cyprus, Greece, Portugal and Spain. The indicators included: (i) HIV epidemiology; (ii) adoption of WHO’s ‘Treat All’ recommendation; (iii) progress towards the UNAIDS global targets of 90–90–90; (iv) adoption/implementation of pre-exposure prophylaxis (PrEP); and (v) adoption/implementation of WHO’s HIV self-testing (HIVST) recommendation. Results HIV incidence varied across countries since 2010, with sustained declines in Portugal and Spain, and marked increases in Greece and Cyprus. By 2016, all four countries have adopted WHO’s ‘Treat All’ recommendation, leading to a marked increase in people receiving ART. Improvements were seen in all 90–90–90 targets, with Portugal achieving those in 2017, but Greece lagging somewhat behind, as of 2016. Portugal and Spain have also started implementing PrEP, and Greece has completed a pilot with no additional access to PrEP for pilot participants and no national programme in place. Cyprus has been the slowest in terms of adopting PrEP and HIVST. Conclusions Countries need to focus on prioritizing effective and comprehensive prevention measures, including HIVST and PrEP, and scale-up access to quality treatment and care for those diagnosed, in order to accelerate the reduction of new HIVs infections and successfully meet the global targets for HIV treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom